Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants

摘要: Disclosed herein are compositions and methods relevant to a novel Drug Metabolism Reserve Physiotype determine the metabolic capacity of human individual. The allows determination innate patient antidepressant stimulant treatment can be predicted diagnosed simply from blood sample. In disclosed method, an individual is genotyped for plurality polymorphisms in gene encoding CYP2C9, CYP2C19 CYP2D6, genotypes used produce four indices, which relate